Artal Group S.A. Deciphera Pharmaceuticals, Inc. Transaction History

Artal Group S.A.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$6.87 - $11.11 $687,000 - $1.11 Million	-100,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$26.46 - $37.15 $2.65 Million - $3.72 Million	-100,000 Reduced 50.0%	100,000 $3.4 Million
Q1 2021 May 14, 2021	SELL	$40.39 - $56.73 $12.1 Million - $17 Million	-300,000 Reduced 60.0%	200,000 $8.97 Million
Q4 2020 Feb 11, 2021	SELL	$51.77 - $66.18 $5.18 Million - $6.62 Million	-100,000 Reduced 16.67%	500,000 $28.5 Million
Q3 2020 Nov 13, 2020	SELL	$43.8 - $58.16 $2.19 Million - $2.91 Million	-50,000 Reduced 7.69%	600,000 $30.8 Million
Q2 2020 Aug 14, 2020	SELL	$37.05 - $65.03 $5.56 Million - $9.75 Million	-150,000 Reduced 18.75%	650,000 $38.8 Million
Q1 2020 May 14, 2020	BUY	$33.63 - $69.4 $18.5 Million - $38.2 Million	550,000 Added 220.0%	800,000 $32.9 Million
Q4 2019 Feb 13, 2020	SELL	$31.7 - $69.93 $7.93 Million - $17.5 Million	-250,000 Reduced 50.0%	250,000 $15.6 Million
Q3 2019 Nov 14, 2019	BUY	$19.95 - $38.85 $9.98 Million - $19.4 Million	500,000 New	500,000 $17 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.